{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:29:58Z","timestamp":1793705398896,"version":"4.5.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Inborn errors of immunity (IEIs), once considered rare disorders characterized primarily by recurrent infections, are now recognized as a rapidly expanding group of diseases encompassing autoimmunity, autoinflammation, allergy, malignancy, and immune dysregulation. Advances in next-generation sequencing, functional immunology, and systems biology have revealed overlap between traditionally distinct disease categories and highlighted the complexity of genotype\u2013phenotype relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>While this evolution has led to the discovery of hundreds of previously unrecognized disorders, it has also challenged conventional diagnostic paradigms and demonstrated how patients may have care spread across multiple specialties, without a clear medical home. These discoveries have also highlighted ongoing challenges translating scientific findings to the clinic including difficulties in accessing genomic testing, interpretation of variants of uncertain significance, impacts of incomplete penetrance and somatic mosaicism, and limited availability of specialized functional assays. Emerging computational approaches, including artificial intelligence, offer opportunities to accelerate diagnosis but cannot replace comprehensive clinical evaluation or longitudinal physician\u2013patient relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>This perspective examines how the diagnostic odyssey for immune dysregulatory disorders has evolved, side-by-side with the changing framework for diagnosing rare immune diseases. We propose an integrated approach combining clinical phenotyping, genomics, functional validation, and multidisciplinary expertise to unite ongoing discovery between clinicians and scientists, diagnostics, and patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001616","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:00:09Z","timestamp":1789635609000},"page":"659-665","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Immune dysregulatory disorders: perspective from solving a diagnostic odyssey"],"prefix":"10.1097","volume":"38","author":[{"given":"Lauren","family":"Crowther","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Allergy & Immunology, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Broderick","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology & Rheumatology, Department of Pediatrics, University of California"},{"name":"Rady Children's Hospital, San Diego, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"R1-20261103","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/bmj.2.5969.486","article-title":"Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients","volume":"2","author":"Hampton","year":"1975","journal-title":"Br Med J"},{"key":"R3-20261103","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s40670-023-01856-2","article-title":"Zebras among us: advocating for the 30 million Americans living with rare disease","volume":"33","author":"Wan","year":"2023","journal-title":"Med Sci Educ"},{"key":"R4-20261103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/imr.13297","article-title":"Inborn errors of immunity: a field without frontiers","volume":"322","author":"Bucciol","year":"2024","journal-title":"Immunol Rev"},{"key":"R5-20261103","doi-asserted-by":"crossref","first-page":"e20250002","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"R6-20261103","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.ajhg.2023.06.009","article-title":"Beyond the exome: what's next in diagnostic testing for Mendelian conditions","volume":"110","author":"Wojcik","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"(Suppl 6)","key":"R7-20261103","doi-asserted-by":"crossref","first-page":"vi44","DOI":"10.1093\/rheumatology\/kez294","article-title":"Current and future advances in genetic testing in systemic autoinflammatory diseases","volume":"58","author":"Schnappauf","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R8-20261103","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"R9-20261103","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI112050","article-title":"Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency","volume":"76","author":"Bonthron","year":"1985","journal-title":"J Clin Invest"},{"key":"R10-20261103","doi-asserted-by":"crossref","first-page":"1497921","DOI":"10.3389\/fimmu.2024.1497921","article-title":"Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation","volume":"15","author":"Cortesi","year":"2024","journal-title":"Front Immunol"},{"key":"R11-20261103","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.13311","article-title":"Inborn errors of immunity illuminate mechanisms of human immunology and pave the road to precision medicine","volume":"322","author":"Hsieh","year":"2024","journal-title":"Immunol Rev"},{"key":"R12-20261103","doi-asserted-by":"crossref","first-page":"e20221755","DOI":"10.1084\/jem.20221755","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J Exp Med"},{"key":"R13-20261103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/ACI.0000000000001059","article-title":"Inborn errors of immunity with atopic phenotypes in the allergy and immunology clinic: a practical review","volume":"25","author":"Taietti","year":"2025","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R14-20261103","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/pai.13571","article-title":"Diverse clinical features and diagnostic delay in monogenic inborn errors of immunity: a call for access to genetic testing","volume":"32","author":"Branch","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"R15-20261103","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2025.10.026","article-title":"2025 Inborn errors of immunity practice parameter: guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS)","volume":"136","author":"Orange","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R16-20261103","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2021.04.015","article-title":"Initial presenting manifestations in 16 486 patients with inborn errors of immunity include infections and noninfectious manifestations","volume":"148","author":"Thalhammer","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"R17-20261103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R18-20261103","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program","volume":"627","year":"2024","journal-title":"Nature"},{"key":"R19-20261103","doi-asserted-by":"crossref","first-page":"EVIDra2400377","DOI":"10.1056\/EVIDra2400377","article-title":"The landscape of genetically driven immune disorders","volume":"5","author":"Peng","year":"2026","journal-title":"NEJM Evid"},{"key":"R20-20261103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"R21-20261103","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaip.2023.03.049","article-title":"Inborn errors of immunity: a role for functional testing and flow cytometry in aiding clinical diagnosis","volume":"11","author":"Ma","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R22-20261103","doi-asserted-by":"crossref","first-page":"101228","DOI":"10.1016\/j.gim.2024.101228","article-title":"The Clinical Genome Resource (ClinGen): advancing genomic knowledge through global curation","volume":"27","year":"2025","journal-title":"Genet Med"},{"key":"R23-20261103","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMsr1406261","article-title":"ClinGen \u2013 the clinical genome resource","volume":"372","author":"Rehm","year":"2015","journal-title":"N Engl J Med"},{"key":"R24-20261103","doi-asserted-by":"crossref","first-page":"e86336","DOI":"10.1172\/jci.insight.86336","article-title":"Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology","volume":"1","author":"Harrison","year":"2016","journal-title":"JCI Insight"},{"key":"R25-20261103","doi-asserted-by":"crossref","first-page":"780134","DOI":"10.3389\/fimmu.2021.780134","article-title":"Implementation of early next-generation sequencing for inborn errors of immunity: a prospective observational cohort study of diagnostic yield and clinical implications in dutch genome diagnostic centers","volume":"12","author":"Elsink","year":"2021","journal-title":"Front Immunol"},{"key":"R26-20261103","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.42139","article-title":"The 2021\u200aEULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist","volume":"74","author":"Romano","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"R27-20261103","doi-asserted-by":"crossref","first-page":"e20250064","DOI":"10.70962\/jhi.20250064","article-title":"Incomplete penetrance in inborn errors of immunity: a skeleton in the closet \u2013 the sequel","volume":"1","author":"Bogunovic","year":"2025","journal-title":"J Hum Immun"},{"key":"R28-20261103","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41586-024-08346-4","article-title":"Monoallelic expression can govern penetrance of inborn errors of immunity","volume":"637","author":"Stewart","year":"2025","journal-title":"Nature"},{"key":"R29-20261103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12687-016-0291-3","article-title":"Survey of family history taking and genetic testing in pediatric practice","volume":"8","author":"Saul","year":"2017","journal-title":"J Community Genet"},{"key":"R30-20261103","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"R31-20261103","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R32-20261103","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1002\/art.21404","article-title":"Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome","volume":"52","author":"Saito","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R33-20261103","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N Engl J Med"},{"key":"R34-20261103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.it.2025.09.003","article-title":"Emerging insights into mosaic errors of immunity","volume":"47","author":"Roosens","year":"2026","journal-title":"Trends Immunol"},{"key":"R35-20261103","doi-asserted-by":"crossref","first-page":"e20241045","DOI":"10.1084\/jem.20241045","article-title":"Identifying genetic errors of immunity due to mosaicism","volume":"222","author":"Schmitz","year":"2025","journal-title":"J Exp Med"},{"key":"R36-20261103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2023.09.036","article-title":"Racial and ethnic disparities in early mortality among patients with inborn errors of immunity","volume":"153","author":"Ong","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"R37-20261103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10142-023-00979-4","article-title":"Health inequity in genomic personalized medicine in underrepresented populations: a look at the current evidence","volume":"23","author":"Tawfik","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"R38-20261103","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1377\/hlthaff.2017.1548","article-title":"Views of primary care providers on testing patients for genetic risks for common chronic diseases","volume":"37","author":"Hauser","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"R39-20261103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.anai.2025.09.026","article-title":"Lessons from the American College of Allergy, Asthma and Immunology inborn errors of immunity survey: advancing diagnostic and therapeutic strategies for the practicing allergist-immunologist","volume":"136","author":"Ariue","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R40-20261103","doi-asserted-by":"crossref","first-page":"108779","DOI":"10.1016\/j.clim.2021.108779","article-title":"Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency","volume":"229","author":"Lanz","year":"2021","journal-title":"Clin Immunol"},{"key":"R41-20261103","doi-asserted-by":"crossref","first-page":"101008","DOI":"10.1016\/j.conctc.2022.101008","article-title":"The ABACHAI clinical trial protocol: safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: a non controlled phase 2 clinical trial","volume":"30","author":"Krausz","year":"2022","journal-title":"Contemp Clin Trials Commun"},{"key":"R42-20261103","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"R43-20261103","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2025.02.026","article-title":"Gene therapy for inborn errors of immunity: current clinical progress","volume":"134","author":"Wijeyesinghe","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R44-20261103","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","article-title":"From target discovery to clinical drug development with human genetics","volume":"620","author":"Trajanoska","year":"2023","journal-title":"Nature"},{"key":"R45-20261103","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1515\/cclm-2018-1126","article-title":"Measuring the chronology of the translational process of molecular genetic discoveries","volume":"57","author":"Rousseau","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"R46-20261103","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.adz4433","article-title":"Performance of a large language model on the reasoning tasks of a physician","volume":"392","author":"Brodeur","year":"2026","journal-title":"Science"},{"key":"R47-20261103","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-021-01010-x","article-title":"GestaltMatcher facilitates rare disease matching using facial phenotype descriptors","volume":"54","author":"Hsieh","year":"2022","journal-title":"Nat Genet"},{"key":"R48-20261103","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ajhg.2024.08.010","article-title":"Assessing the utility of large language models for phenotype-driven gene prioritization in the diagnosis of rare genetic disease","volume":"111","author":"Kim","year":"2024","journal-title":"Am J Hum Genet"},{"key":"R49-20261103","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/jamia\/ocag045","article-title":"Applying natural language processing and large language models to clinical notes for phenotyping and diagnosing rare diseases: a systematic review","volume":"33","author":"Kim","year":"2026","journal-title":"J Am Med Inform Assoc"},{"key":"R50-20261103","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41746-025-01452-1","article-title":"A phenotype-based AI pipeline outperforms human experts in differentially diagnosing rare diseases using EHRs","volume":"8","author":"Mao","year":"2025","journal-title":"NPJ Digit Med"},{"key":"R51-20261103","doi-asserted-by":"crossref","first-page":"100830","DOI":"10.1016\/j.gim.2023.100830","volume":"25","author":"Meng","year":"2023","journal-title":"Genet Med"},{"key":"R52-20261103","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2025.06.015","article-title":"Current perspectives and challenges of using artificial intelligence in immunodeficiencies","volume":"156","author":"Riviere","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"R53-20261103","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2025.10.022","article-title":"Machine learning-assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling","volume":"157","author":"Schwitzkowski","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"R54-20261103","first-page":"668","article-title":"The impact of GeneMatcher on international data sharing and collaboration","volume":"43","author":"Hamosh","year":"2022","journal-title":"Hum Mutat"},{"key":"R55-20261103","first-page":"760","article-title":"Discovery of over 200 new and expanded genetic conditions using GeneMatcher","volume":"43","author":"McWalter","year":"2022","journal-title":"Hum Mutat"},{"key":"R56-20261103","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13023-021-01916-z","article-title":"PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data","volume":"16","author":"Wohler","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R57-20261103","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/ajmg.a.70090","article-title":"VariantMatcher: Phenotypic and genomic data sharing to facilitate variant classification and disease gene discovery","volume":"200","author":"Villela","year":"2026","journal-title":"Am J Med Genet A"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:00:25Z","timestamp":1793703625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0000000000001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001616","relation":{},"ISSN":["1531-698X","1040-8703"],"issn-type":[{"value":"1531-698X","type":"electronic"},{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}